Disparities Associated with Advanced Prostate Cancer Stage at Diagnosis
Overview
Affiliations
This study expands on a previous report (focusing on health insurance status and race/ethnicity) to present effects of age, socioeconomic status, hospital type, and other factors (e.g., type of Medicaid and Medicare coverage, insurance-by-race/ethnicity interactions) on advanced-stage (III/IV) at prostate cancer diagnosis. Invasive (Stages I-IV) prostate cancer cases diagnosed during 1998-2004 were extracted from the National Cancer Database (N=687,464). Independent of health-insurance and race/ethnicity, socioeconomic status was a significant predictor of advanced stage at diagnosis, with patients residing in areas with lower socioeconomic characteristics having significantly increased odds. Those treated at community-cancer-centers had significantly decreased odds (versus teaching/research-facilities). Significantly increased odds were also observed among uninsured-Blacks, Medicare-insured-Blacks, Medicaid-insured-Blacks, Medicare-insured-Hispanics, and Medicare-insured-other-racial/ethnic-minorities 65 years old and older (versus corresponding White-populations). The impact of prostate cancer screening on reducing mortality remains debatable. Still, our results suggest improvements in multiple factors that affect access-to-care may achieve earlier diagnosis and, therefore, a potentially more treatable disease.
Shaw B, Walter F, Hamilton W, Martins T Br J Gen Pract. 2023; 73(732):e502-e510.
PMID: 37253629 PMC: 10242866. DOI: 10.3399/BJGP.2022.0554.
Racial Differences in Incident Genitourinary Cancer Cases Captured in the National Cancer Database.
Wolff D, Monaghan T, Gordon D, Michelson K, Jones T, Khargi R Medicina (Kaunas). 2021; 57(7).
PMID: 34209546 PMC: 8303448. DOI: 10.3390/medicina57070671.
Epidemiological Determinants of Advanced Prostate Cancer in Elderly Men in the United States.
Jayasekera J, Onukwugha E, Cadham C, Tom S, Harrington D, Naslund M Clin Med Insights Oncol. 2019; 13:1179554919855116.
PMID: 31263375 PMC: 6595651. DOI: 10.1177/1179554919855116.
Geographical Variations in Prostate Cancer Outcomes: A Systematic Review of International Evidence.
Dasgupta P, Baade P, Aitken J, Ralph N, Chambers S, Dunn J Front Oncol. 2019; 9:238.
PMID: 31024842 PMC: 6463763. DOI: 10.3389/fonc.2019.00238.
Wallace T, Qian J, Avital I, Bay C, Man Y, Wellman L J Cancer. 2018; 9(12):2191-2202.
PMID: 29937939 PMC: 6010688. DOI: 10.7150/jca.22846.